REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Alpen Pharma Kft. (Hungary)

Main Activities: Marketing Research and Public Opinion Polling
Full name: Alpen Pharma Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

Alpen Pharma Kft. is based in Hungary. The head office is in Budapest. The company operates in the Marketing Research and Public Opinion Polling sector. The enterprise was incorporated on July 14, 2016. It currently has a total number of 11 (2024) employees. The latest financial highlights indicate a net sales revenue drop of 21.69% in 2024. There was a total negative growth of 28.07% in Alpen Pharma Kft.’s total assets over the same period. In 2024, Alpen Pharma Kft.’s net profit margin decreased by 4.25%.

Headquarters
Soroksari ut 48. 15. ep. 1. emelet 2.
Budapest; Budapest; Postal Code: 1095

Contact Details: Purchase the Alpen Pharma Kft. report to view the information.

Website: http://www.alpenpharma.com

Basic Information
Total Employees:
Purchase the Alpen Pharma Kft. report to view the information.
Registered Capital:
Purchase the Alpen Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Alpen Pharma Kft. report to view the information.
Incorporation Date:
July 14, 2016
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Alpen Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-21.69%▼
Total operating revenue
-21.5%▼
Operating profit (EBIT)
-64.94%▼
EBITDA
-61.57%▼
Net Profit (Loss) for the Period
-97.98%▼
Total Assets
-28.07%▼
Total Equity
1.16%▲
Operating Profit Margin (ROS)
-4.23%▼
Net Profit Margin
-4.25%▼
Return on Equity (ROE)
-56.43%▼
Quick Ratio
0.28%▲
Cash Ratio
0.14%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo